Atom | Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Due Dates: April 13, 2027: Full application deadline (single-stage submission)

Funding Amounts: €9–10 million per project; up to 4 grants; typical project duration 3–5 years; 100% funding for eligible costs.

Summary: Supports research to develop monoclonal antibody therapies for the prevention and treatment of infections caused by specific Flaviviruses, advancing EU preparedness for viral outbreaks.

Key Information: Applicants must target only one Flavivirus per proposal; clinical study annex required.

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Sign in to see full grant listing